ask="19.50"
ask_size="2700"
average_daily_volume="147187"
bid="N/A"
bid_size="N/A"
book_value="6.01"
change="-0.13"
change_from_200_day_moving_average="0.84"
change_from_50_day_moving_average="0.08"
change_from_52_week_high="-2.66"
change_From_52_week_low="4.77"
change_in_percent="-0.77%"
close="16.84"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.77"
ebitda="-62.58M"
eps_estimate_current_year="-3.11"
eps_estimate_next_quarter="-0.79"
eps_estimate_next_year="-1.70"
ex_dividend_date="N/A"
float_shares="11847000"
high="17.32"
high_52_weeks="19.50"
last_trade_date="3/8/2017"
last_trade_price="16.84"
last_trade_size="3988"
last_trade_time="4:00pm"
low="16.78"
low_52_weeks="12.07"
market_capitalization="374.17M"
moving_average_200_day="16.00"
moving_average_50_day="16.76"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="32.25"
open="16.99"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="+5.27%"
percent_change_from_50_day_moving_average="+0.50%"
percent_change_from_52_week_high="-13.64%"
percent_change_from_52_week_low="+39.52%"
previous_close="16.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.83"
price_per_sales="659.19"
revenue="572000.00"
shares_outstanding="22219000"
short_ratio="31.81"
stock_exchange="NGM"
symbol="ADMS"
volume="105496"
weeks_range_52="12.07 - 19.50"
